Robert T. Heelan

12.3k citations
78 papers · 9.7k · 3 hit papers · h-index 38

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research

Papers in

    • Lung Cancer Treatments and Mutations 34
    • Lung Cancer Diagnosis and Treatment 21
    • Medical Imaging and Pathology Studies 7
    • Lung Cancer Research Studies 19
    • Cancer Treatment and Pharmacology 9
    • HER2/EGFR in Cancer Research 8

Robert T. Heelan

77 papers receiving 9.4k citations

Robert T. Heelan's Hit Papers

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib 2005 · 1.2k citations
1.2k0+7+14Years since publication10002.0k3.0k

Peers

Robert T. Heelan
Comparison fields: 5 of 125
  • Pulmonary and Respiratory Medicine 7.2k
  • Oncology 5.5k
  • Cancer Research 1.5k
  • Radiology, Nuclear Medicine and Imaging 1.0k
  • Molecular Biology 2.5k
Replace Michelle S. Ginsberg with:
Michelle S. Ginsberg United States
Sanja Đačić United States
Christine Théodore France
Christophe Massard France
Christopher G. Willett United States
Lee S. Rosen United States
Marie Wislez France
Maciej Krzakowski Poland
Vera Hirsh Canada
Christian Manegold Germany
Robert T. Heelan relative to Michelle S. Ginsberg United States Michelle S. Ginsberg's profile →
Citations per field
00.5×1.6×
Michelle S. Ginsberg · 1×
Citations per year

Countries citing papers authored by Robert T. Heelan

Since Specialization
Citations

This map shows the geographic impact of Robert T. Heelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Heelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Heelan more than expected).

Fields of papers citing papers by Robert T. Heelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Heelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Heelan. The network helps show where Robert T. Heelan may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert T. Heelan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert T. Heelan Line = papers co-authored together Robert T. Heelan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
Hit paper breakdown →
20043487
2
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Hit paper breakdown →
20051228
3
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2004628
4 1984397
5 1994372
6 1993292
7 2008237
8 1997210
9 2003199
10 2004147
11 2005117
12 2006115
13 1995104
14 1985103
15 2008101
16 199794
17 198390
18 199689
19 200386
20 200781

About Robert T. Heelan

Robert T. Heelan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 78 papers that have together received 9.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Research Studies (19 papers), Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer therapeutics and mechanisms (8 papers), Medical Imaging and Pathology Studies (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.2k citations), Oncology (5.5k citations), Cancer Research (1.5k citations), Radiology, Nuclear Medicine and Imaging (1.0k citations) and Molecular Biology (2.5k citations). Robert T. Heelan has collaborated with scholars based in United States, Russia and Ireland. Frequent co-authors include Mark G. Kris, Vincent A. Miller, Maureen F. Zakowski, William Pao, Valerie W. Rusch, Harold Varmus, Bhuvanesh Singh, Richard K. Wilson, Katerina Politi and Lucinda A. Fulton. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact